NDA 019264 describes PENTAM, which is a drug marketed by
Fresenius Kabi Usa,
Pai Holdings,
X-gen Pharms Inc,
Avet Lifesciences,
Baxter Hlthcare,
Hospira,
Pharmobedient, and
Watson Labs, and is included in nine NDAs. It is available from
one supplier. Additional details are available on the
PENTAM profile page.
The generic ingredient in PENTAM is
pentamidine isethionate. There is one
drug master file entry for this compound. Five
suppliers are listed for this compound. Additional details are available on the
pentamidine isethionate profile page.